Excerpts

A clear trend towards more patients undergoing antileukemic therapy (2005–2011: 19% vs. 2012 and after: 71%) can be observed.

Correlation analyses implied DC infiltration was somewhat linked to homing of T cells to MSI-H tumors but, overall, the association between APC and T cell frequencies displayed a negative trend regardless of MSI status.

CRC, a highly preventable disease, continues to remain the second most lethal cancer in the US with an increasing trend globally [ 1 ].

Notably, secondary liver malignancies and concurrent exemestane use were associated with an increased risk of hepatitis, while the absence of anti-HBs antibodies showed a trend, though not statistically significant, toward increased HBVr risk, which may be due to small sample size and missing antiHBs titer data.

Patients with CD8 T RM -high, CD39+ CD8 T RM -high, and PD-L1+ CD8 T RM -high tumors showed a trend of better survival; however, the finding was not statistically significant ( Figure 4 ).

A p -value of ≤0.10 was considered as borderline significant, and ≤0.05 as statistically significant. 3.

The intake of dietary calcium showed a trend similar to that reported in previous meta-analyses; however, these studies focused on BC incidence [ 107 , 108 ].

The results of our study confirm that the changes in the glycosylation level of fibrinogen were highly significant, with haptoglobin, serotransferrin, and, to some degree, hemopexin, also useful in the differentiation of LC patients from control subjects.

There was a similar but borderline significant trend for BAFF ( P trend = 0.08; Table S4 ).

There was a significant trend for immune biomarker levels according to the duration of smoking (≤5 years, >5 years), with the exception of MCP1 ( Table S5 ).

Preclinical data suggests that anti-PD-1 therapy and radiotherapy are best given concurrently, as there may be significant synergy between these two therapies [ 50 , 51 ].

In addition, tumor involvement in the optic apparatus and the GTV volume showed a trend towards contributing to the onset of this side effect.

However, this increase did represent a large relative increase (304.00%) in methylation, suggesting that it is likely to be significant from a biological standpoint.

PDAC cells treated with CM from IL-17RB OE PSCs showed a trend towards increased OCR compared with control CM and a significant increase of the OCR compared with naive tumor cells ( Figure 5 A).

[ 24 ] also investigated the effects of microRNA-486 in the MMTV-PyMT model; the authors showed a trend to decrease microRNA-486 expression in skeletal muscle and elevated PTEN expression and lower pAKT, without changes in muscle phenotype [ 24 ].

These showed the greatest benefit for the monotherapy olaparib treatment in the BRCAm subgroup, though several other genes also showed a positive trend.

showed that a low PNI and a decreasing trend in pretreatment BMI rather than baseline BMI category are associated with worse response and survival rates in cancer patients who received immune checkpoint inhibition [ 28 ].

However, there was a decreasing trend in the TG in both oxygen status groups in MCF7 and MDA-MB-231 cells ( Figure 4 A).

In contrast with a previous study [ 12 ], we did not find a significant interaction between sex and time of distress level 6 months apart, but only a small trend to a worsening in males.

In that study, OCA2, KITLG, SLC24A4, and TPCN2, which are all associated with blond hair or blue eyes, did not show a nominally significant association with the risk of CM or BCC.

Overall survival data were not mature, however, there was a strong trend towards an improved OS in the pyrotinib arm (HR 0.46; 95% CI 0.22–0.99).

However, compared to the earlier years, there was an increasing trend for all sites combined for female cancers overall between 2005 and 2017 (APC = 1.1%), and a decreasing trend for all sites combined for male cancers overall between 2007 and 2017 (APC = −0.3%).

This increase was primarily due to ageing and increasing population (95% age, 66.1% growth for women, and 119.4% age, 25.4% growth for men), while disease risk for all cancers combined has a decreasing trend (−4.5% for women and −48.8% for men).

This information was not recorded in the same way across the two cohorts (see methods), but a clear difference was apparent.

From the individual patient’s perspective, the financial burden of out-of-pocket expenses based on the price of the full vial size may be significant, especially in disadvantaged populations.